iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 96.77
-8.43 (-8.01%)
Jul 13, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 31.13 billion as of July 10, 2026. Its market cap has increased by 75.29% in one year.
Market Cap
31.13B
Enterprise Value
32.54B
Revenue
2.46B
Ranking
n/a
PE Ratio
46.05
Stock Price
96.77
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 31.13B, an increase of 168.00%. That is a compound annual growth rate of 18.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 31.13B | 45.77% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 39.56B |
| Intco Medical Technology | 29.80B |
| Imeik Technology Development | 26.96B |
| Andon Health | 24.66B |
| Zhende Medical | 23.02B |
| Jiangsu Hualan New Pharmaceutical Material | 17.65B |
| Winner Medical | 16.11B |
| Shenyang Xingqi Pharmaceutical | 14.50B |